Skip to content

Application of anisodamine hydrobromide combined with opioids in painless colonoscopy

Application of anisodamine hydrobromide combined with opioids in painless colonoscopy

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070167
Enrollment
Unknown
Registered
2023-04-04
Start date
2023-03-25
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesiology

Interventions

Group A:Cyclopofol 0.4mg/kg, Afentanil 5ug/kg
Group R:Cyclopofol 0.4mg/kg, remifentanil 0.1ug/kg

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 50 ~ 70 years old; BMI=30kg/m2; ASA? ~ ? grade.

Exclusion criteria

Exclusion criteria: Contraindications for colonoscopy; The patients with intestinal polyps detected were older at the time of operation; More serious heart, lung and brain diseases; History of allergy to narcotic drugs; Being overweight; Severe hypertension; Sinus tachycardia; Various reasons can not cooperate, etc.

Design outcomes

Primary

MeasureTime frame
Degree and number of intestinal spasms;Additional drug situation;Detection of intestinal polyps;Adverse reaction;

Secondary

MeasureTime frame
Induction time;Inspection time;Recovery time;hemodynamics;Patient satisfaction;Anesthesiologist satisfaction;

Countries

China

Contacts

Public Contactliuweiwei

Weifang People's Hospital

liuweiwei370786@163.com15269612968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026